BUPLANT Trademark

Trademark Overview

On Thursday, September 20, 2012, a trademark application was filed for BUPLANT with the United States Patent and Trademark Office. The USPTO has given the BUPLANT trademark a serial number of 85734080. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 30, 2016. This trademark is owned by Titan Pharmaceuticals, Inc.. The BUPLANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
buplant

General Information

Serial Number85734080
Word MarkBUPLANT
Filing DateThursday, September 20, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 30, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2013

Trademark Statements

Goods and ServicesPharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 24, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTitan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940801921
Party NameTitan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940801921

Trademark Events

Event DateEvent Description
Tuesday, May 31, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 30, 2016ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, October 13, 2015EXTENSION 5 GRANTED
Tuesday, September 29, 2015EXTENSION 5 FILED
Tuesday, September 29, 2015TEAS EXTENSION RECEIVED
Thursday, April 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, April 22, 2015EXTENSION 4 GRANTED
Friday, April 10, 2015EXTENSION 4 FILED
Friday, April 10, 2015TEAS EXTENSION RECEIVED
Wednesday, October 15, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, October 14, 2014EXTENSION 3 GRANTED
Monday, October 6, 2014EXTENSION 3 FILED
Monday, October 6, 2014TEAS EXTENSION RECEIVED
Friday, March 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, March 27, 2014EXTENSION 2 GRANTED
Friday, March 7, 2014EXTENSION 2 FILED
Friday, March 7, 2014TEAS EXTENSION RECEIVED
Monday, January 6, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 31, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 12, 2013TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, October 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, October 17, 2013EXTENSION 1 GRANTED
Thursday, October 17, 2013EXTENSION 1 FILED
Thursday, October 17, 2013TEAS EXTENSION RECEIVED
Tuesday, April 23, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2013NOTICE OF PUBLICATION
Thursday, January 17, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 17, 2013ASSIGNED TO EXAMINER
Monday, September 24, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 24, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

buplant system formulation matrix sustained pharmaceuticals treatment drugs based release drug